Abnormal Proliferation
Cytotoxic T Cells-mediated Immune Response
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 20, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Jackson W Mace1,2,3, Matthew D Smith1, Sachin P Gadani1,4
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Macrophage migration inhibitory factor (MIF) tautomerase activity drives neuroinflammation and neurodegeneration in multiple sclerosis (MS). Targeting MIF tautomerase may offer new therapeutic strategies for progressive MS by reducing immune cell infiltration and pathology.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: